factual

Moderna Sold Platform Access Rather Than Single Drugs

Moderna pitched itself as a platform for sending RNA into cells, not a single drug company, and used that to sign early deals with AstraZeneca and Alexion totaling about $300 million upfront, while keeping the rest of the platform for itself.

factualpending

Speaker

Jason Kelly

Evidence Quote

“they did the deal with AstraZeneca, it was just in one area, but they reserved all the rest of their platform for themselves.”

Source

Moderna: The Software of Life— Business Breakdowns
Created: 11/15/2026, 7:57:10 PM

Your notes

Loading notes...